Boston Scientific Acquires Relievant Medsystems, Inc.

Boston Scientific Acquires Axonics, Inc.

November 15, 2024

Medical Devices

Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation agreed to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition expands Boston Scientific’s electrophysiology and structural heart portfolios by adding Baylis’s RF NRG and VersaCross transseptal platforms and complementary guidewires, sheaths and dilators; Baylis was expected to generate nearly $200 million in net sales in 2022.

Boston Scientific Acquires Vertiflex from H.I.G. BioHealth Partners

June 18, 2019

Medical Devices

Boston Scientific acquired Vertiflex, Inc., a Carlsbad-based developer of the Superion interspinous spacer for lumbar spinal stenosis, for approximately $465 million in cash plus contingent payments. The transaction was announced in May 2019 and completed in June 2019; Vertiflex had been backed by H.I.G. BioHealth Partners.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.